Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn's disease

被引：1
|
作者：
Dussias, N. [1 ]
Rizzello, F. [1 ]
Calabrese, C. [1 ]
Passino, A. Sanna [1 ]
Melotti, L. [1 ]
Scaioli, E. [1 ]
Belluzzi, A. [1 ]
Gionchetti, P. [1 ]
机构：
[1] Univ Bologna, Dept Surg & Med Sci, Bologna, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.689
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P568
引用
收藏
页码：S528 / S528
页数：1
相关论文
共 50 条
  • [1] Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease
    Townsend, Tristan
    Razanskaite, Violeta
    Dodd, Susanna
    Storey, Daniel
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Penman, Douglas
    Watters, Christopher
    Swaminathan, Mira
    Sabine, Joseph
    Chapman, Adam
    Smith, Philip J.
    Flanagan, Paul K.
    Reilly, Ian
    Bodger, Keith
    Subramanian, Sreedhar
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1341 - 1352
  • [2] Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn?s disease
    Melotti, Laura
    Dussias, Nikolas Konstantine
    Salice, Marco
    Calabrese, Carlo
    Baldoni, Monia
    Scaioli, Eleonora
    Belluzzi, Andrea
    Mazzotta, Elena
    Gionchetti, Paolo
    Rizzello, Fernando
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 230 - 234
  • [3] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [4] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
    Sharip, Mohmmed Tauseef
    Nishad, Nilanga
    Pillay, Lushen
    Goordoyel, Nilkantsingh
    Goerge, Samuel
    Subramanian, Sreedhar
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [5] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Lewis, James D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica L.
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Long, Millie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
  • [6] An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
    Onali, Sara
    Pugliese, Daniela
    Caprioli, Flavio Andrea
    Orlando, Ambrogio
    Biancone, Livia
    Nardone, Olga Maria
    Imperatore, Nicola
    Fiorino, Gionata
    Cappello, Maria
    Viola, Anna
    Principi, Maria Beatrice
    Bezzio, Cristina
    Aratari, Annalisa
    Carparelli, Sonia
    Mazzuoli, Silvia
    Manguso, Francesco
    Grossi, Laurino
    Bodini, Giorgia
    Ribaldone, Davide
    Mocci, Giammarco
    Miranda, Agnese
    Minerba, Luigi
    Favale, Agnese
    Grova, Mauro
    Scucchi, Ludovica
    Segato, Simone
    Fries, Walter
    Castiglione, Fabiana
    Armuzzi, Alessandro
    Fantini, Massimo C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (08): : 1279 - 1287
  • [7] Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment
    Biemans, Vince B. C.
    van der Woude, C. Janneke
    Dijkstra, Gerard
    van der Meulen-de Jong, Andrea E.
    Lowenberg, Mark
    de Boer, Nanne K.
    Oldenburg, Bas
    Srivastava, Nidhi
    Jansen, Jeroen M.
    Bodelier, Alexander G. L.
    West, Rachel L.
    de Vries, Annemarie C.
    Haans, Jeoffrey J. L.
    de Jong, Dirk
    Hoentjen, Frank
    Pierik, Marieke J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (01) : 123 - 134
  • [8] MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE
    Razanskaite, Violeta
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Storey, Daneil
    Watters, Christopher
    Penman, Douglas
    Swaminathan, Mira
    Sabine, Joseph
    Chapman, Adam
    Reilly, Ian
    Flanagan, Paul
    Bodger, Keith
    Subramanian, Sreedhar
    [J]. GUT, 2019, 68 : A100 - A100
  • [9] Crohn's disease: vedolizumab vs. ustekinumab after anti-TNF pretreatment
    Simon, Annika
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (09): : 1168 - 1170
  • [10] The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease
    Macaluso, F. S.
    Grova, M.
    Saladino, M.
    Demarzo, M. G.
    Privitera, A. C.
    Giangreco, E.
    Garufi, S.
    Renna, S.
    Casa, A.
    Ventimiglia, M.
    Cappello, M.
    Fries, W.
    Orlando, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I359 - I359
12345